573. Vector Free Genome Editing of Immune Cells for Cell Therapy

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)33381-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Genome Editing Gene Therapy for Duchenne Muscular Dystrophy

Journal of Neuromuscular Diseases
Neurology
2015English

CRISPR/Cas9—Advancing Orthopoxvirus Genome Editing for Vaccine and Vector Development

Viruses
VirologyInfectious Diseases
2018English

From Genomics to Gene Therapy: Induced Pluripotent Stem Cells Meet Genome Editing

Annual Review of Genetics
Genetics
2015English

Development of Gene Therapy Using Genome Editing Technology

Journal of Hematopoietic Cell Transplantation
2018English

Genome Editing for All

Nature Biotechnology
Applied MicrobiologyBiotechnologyBiomedical EngineeringMolecular MedicineBioengineering
2014English

Gene Delivery Technologies for Efficient Genome Editing: Applications in Gene Therapy

2016English

Poking Cells for Efficient Vector-Free Intracellular Delivery

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2014English

Role of the Vector Genome and Underlying Factor IX Mutation in Immune Responses to AAV Gene Therapy for Hemophilia B

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2014English

ITR-Seq, a Next-Generation Sequencing Assay, Identifies Genome-Wide DNA Editing Sites in Vivo Following Adeno-Associated Viral Vector-Mediated Genome Editing

BMC Genomics
BiotechnologyGenetics
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy